Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

Bibliographic Details
Main Authors:	Laurence C. Cheung, Mark N. Cruickshank, Anastasia M. Hughes, Sajla Singh, Grace-Alyssa Chua, Jette Ford, Emanuela Ferrari, Joyce Oommen, Sébastien Malinge, Richard B. Lock, Ursula R. Kees, Rishi S. Kotecha
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2019-07-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/8985

Internet